Entheon Biomedical Corp. — Form D
Entheon Biomedical Corp. of Belcarra, A1, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-22. The offering totals $1.3M, of which $77K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-06-22
- Form: D
- Accession: 0001814903-20-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $77K
- Remaining: $1.2M
- Investors: 4
- Date of first sale: 2020-06-03
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-369415
Issuer
- Name: Entheon Biomedical Corp.
- CIK: 0001814903
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2019
- Address: 3694 Marine Avenue, Belcarra, A1, V3H 4R8
- Phone: (604) 562-3932
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Christopher Gondi | Director | Coquitlam, A1 |
| Andrew Hegle | Director | Coquitlam, A1 |
| Timothy Ko | Director | Coquitlam, A1 |
| Brandon Schwabe | Director | Coquitlam, A1 |
| Timothy Ko | Executive Officer | Coquitlam, A1 |
| Kelly Pladson | Executive Officer | VANCOUVER, A1 |
| Brandon Schwabe | Executive Officer | Coquitlam, A1 |
More